U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, allowing the ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...
“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...
The Tryvio REMS program was established due to the risk of birth defects associated with the ERA drug class. Prior to dispensing Tryvio, patients of reproductive potential were required to report a ...
The FDA is reinstating fired probationary workers after a federal judge ruled their terminations were unlawful and must be ...
The FDA has granted orphan drug designation to PEP-010 for pancreatic cancer, advancing its development as a potential novel ...
Sirolimus, the active ingredient in Felycin-CA1, at a higher dose is used as an immunosuppressant in human patients receiving ...
These medications are not FDA-approved, meaning they do not undergo the rigorous testing for safety, effectiveness, and ...
The FDA granted fast track designation to ATSN-201 for the treatment of X-linked retinoschisis, according to a press release ...
It’s time to revamp the FDA’s “generally recognized as safe,” or GRAS, program that allows companies to add untested ...
Five years after the World Health Organization declared the COVID-19 outbreak a global pandemic, Dr. Sara Cody — the Santa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results